$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
靶向药卡博替尼治疗肝癌的推荐剂量
2025-10-19 11:44:20
Check Details
卡博替尼可以和乐伐替尼一起服用治疗肝癌吗?
2025-10-19 11:44:20
Check Details
多吉美2021年医保报销后一个月多少钱?
2025-10-19 11:44:20
Check Details
患者服用瑞戈非尼能使肿瘤缩小吗?
2025-10-19 11:44:20
Check Details
肝癌晚期服用卡博替尼可以延长多久的生存期?
2025-10-19 11:44:20
Check Details
用多吉美治疗肝癌还需要吃其他药物吗?
2025-10-19 11:44:20
Check Details
多吉美治疗肝细胞癌最多吃多少年?
2025-10-19 11:44:20
Check Details
乐伐替尼可一线治疗不可切除的肝癌
2025-10-19 11:44:20
Check Details
肝癌晚期服用多吉美的注意事项
2025-10-19 11:44:20
Check Details
乐伐替尼针对中国晚期HBV相关肝癌收获理想的治疗效果
2025-10-19 11:44:20
Check Details
肝癌患者每天吃一粒多吉美有效果吗?
2025-10-19 11:44:20
Check Details
患者须知:使用乐伐替尼对肝脏功能的要求
2025-10-19 11:44:20
Check Details
1
2
...
2870
2871
2872
2873
2874
2875
2876
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
2
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
3
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Vemurafenib (Zelboraf) Complete Medication Guide
6
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
7
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
8
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
9
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
10
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
11
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
12
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth